Literature DB >> 8239228

Interferon-alpha 2b: a new treatment for polycythemia vera.

R T Silver1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8239228     DOI： 10.7326/0003-4819-119-11-199312010-00006

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  5 in total

1.  Treatment of polycythemia vera with recombinant interferon.

Authors:  Richard T Silver
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera.

Authors:  S Sacchi; P Leoni; M Liberati; A Riccardi; A Tabilio; P Tartoni; C Messora; A Vecchi; L Bensi; S Rupoli
Journal:  Ann Hematol       Date:  1994-05       Impact factor: 3.673

Review 3.  Novel agents for the treatment of polycythemia vera: an insight into preclinical research and early phase clinical trials.

Authors:  Leslie Padrnos; Ruben Mesa
Journal:  Expert Opin Investig Drugs       Date:  2020-07-16       Impact factor: 6.206

Review 4.  Update on the treatment of polycythemia vera with recombinant interferon alfa or imatinib mesylate.

Authors:  Richard T Silver
Journal:  Curr Hematol Malig Rep       Date:  2007-02       Impact factor: 4.213

Review 5.  The treatment of polycythaemia vera: an update in the JAK2 era.

Authors:  G Finazzi; T Barbui
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.